Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Dexmedetomidine hydrochloride

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride is a prescription injectable solution used for short-term sedation in intensive care settings. It works as an alpha-2 adrenergic agonist to provide calming effects during procedures or mechanical ventilation. Administered intravenously at 4 mcg/mL strength in 50 mL or 100 mL bottles, it's approved as a generic drug by Sagent Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov